![](/img/cover-not-exists.png)
Late-Term Clinical Outcomes With Zotarolimus- and Sirolimus-Eluting Stents: 5-Year Follow-Up of the ENDEAVOR III (A Randomized Controlled Trial of the Medtronic Endeavor Drug [ABT-578] Eluting Coronary Stent System Versus the Cypher Sirolimus-Eluting Coronary Stent System in De Novo Native Coronary Artery Lesions)
David E. Kandzari, Laura Mauri, Jeffrey J. Popma, Mark A. Turco, Paul A. Gurbel, Peter J. Fitzgerald, Martin B. LeonVolume:
4
Year:
2011
Language:
english
Pages:
8
DOI:
10.1016/j.jcin.2010.12.014
File:
PDF, 704 KB
english, 2011